In the second phase, mast cells are activated by IgE-binding epitopes, and release mediators such as histamine, prostaglandins, leukotrienes, which cause dilatation of blood vessels, constriction of the bronchioles, increased mucus secretion, and other allergy symptoms caused by inflammatory mediators binding to receptors on target cells. This evidence concerns the gene IGHE and allergic disease.